GSK3B and familial pancreatic carcinoma: Therefore, elucidating the conceivable contribution of GSK3β to the interaction of PSCs and CAFs with tumor cells may provide a new strategy for targeting the tumor-promoting stroma, thereby combatting chemoresistance in pancreatic cancer.